header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The murine primary KO99L cell line was established by cultivating tumoral thymocytes from a tPTEN-/- mouse. Mice carrying a T cell-specific deletion […]
The primary KO99L cell line was established by cultivating tumoral thymocytes from a tPTEN-/- mouse. KO99L cells were transduced with a […]
Saccharomyces cerevisiae expressing under the GAL promoter either the wild-type rat liver CPT1, mutated rat liver CPT1 or chimeric CPT. CPT1A activity […]
Transgenic mouse model carrying the myotonic dystrophy type 1 (DM1) locus (45kb of human sequences) with the DMPK gene and about 300 unstable CTG […]
This transgenic mice model ("DMSXL") contains large human genomic DNA sequence carrying the DMPK gene with very large repeat (>1200 CTG). […]
We can provide mice a nutritional model of mice which become either type 2 diabetic without obesity, or obese and diabetic or mainly obese. […]
The class B, type I scavenger receptor (Srb1 or Scarb1) is a cell surface HDL receptor. It plays a key role in determining the levels of plasma […]
We introduced the Prkcd G510S mutation that we previously associated to a Mendelian cause of SLE in the mouse genome, by means of CRISPR-Cas9 gene […]
Amyloidosis is a rare disease caused by extracellular deposition of insoluble abnormal fibrils derived from aggregation of a misfolded variant of a […]
100% of the animals spontaneously tumor in the distal part of the colon after 7 month of age, or within 5 weeks after bone marrow transfer. The […]
We introduced the Prkcd G510S mutation that we previously associated to a Mendelian cause of SLE in […]
Transgenic mouse model carrying the myotonic dystrophy type 1 (DM1) locus (45kb of human sequences) […]
Amyloidosis is a rare disease caused by extracellular deposition of insoluble abnormal fibrils […]
Rat monoclonal antibody recognizing the CD4 mouse T-cell subset marker. […]
Mouse monoclonal antibodies recognizing the HOX11 gene product. […]
Invalidation of apelin in adipose tissue with an aP2CRE-LoxAPL mouse […]
These germ free mice are colonized with human microflora and fed a high fat diet which allows the […]
The primary KO99L cell line was established by cultivating tumoral thymocytes from a tPTEN-/- mouse. […]
The mice are hemizygous for the human apolipoprotein A2 (ApoA2) gene expressed under the control of […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.